Provides compliance consulting services to pharmaceutical companies.
Jul 2026Revenue $9.48M/yrExpenses $9.64M/yr
No trend
Figures by year
When will Pharma-Bio Serv be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jul 2026, revenue was $9.48M and expenses $9.64M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Oct 2025 | $9.00M | $9.64M | −$638K |
| Oct 2024 | $9.51M | $10.8M | −$1.29M |
| Oct 2023 | $17.0M | $15.9M | $1.12M |
| Oct 2022 | $19.4M | $18.2M | $1.17M |
| Oct 2021 | $20.1M | $24.0M | −$3.85M |
| Oct 2020 | $21.6M | $19.3M | $2.23M |
| Oct 2019 | $19.5M | $17.8M | $1.70M |
| Oct 2018 | $17.8M | $19.1M | −$1.26M |
| Oct 2017 | $13.3M | $14.1M | −$778K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.